Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid

Journal of Neuroscience Research

Volumn 71, Issue 1, 2003, Pages 79-88

  Carlson, Noel G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Excitotoxicity; Neuroprotection; NMDA; NSAIDs, prostanoids

Indexed keywords

17 PHENYLTRINORPROSTAGLANDIN E2; 2 (ACETOXYPHENYL)HEPT 2 YNYL 2 SULFIDE; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ACETYLENE; ALKYNES; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DEATH; CEREBRAL CORTEX; CULTURE TECHNIQUES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; ISOENZYMES; MEMBRANE PROTEINS; MICE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; NITROBENZENES; POLYAMINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFIDES; SULFONAMIDES;

EID: 0037215379     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10465     Document Type: Article

References (52)

1. Akaike A, Kaneko S, Tamura Y, Nakata N, Shiomi H, Ushikubi F, Narumiya S. 1994. Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 663:237.
2. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer, Kaufmann WE, Worley PF, Isakson P, Markowdka AL. 2001. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxgenase-2 transgenic mice. J Neurosci 21:8198-8209.
3. Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N. 2001. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76:1895-1904.
4. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391:281-285.
5. Breimer JCS. 1996. Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 17:789-794.
6. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. 2000. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97:11280-11285.
7. Carlson NG, Bacchi A, Rogers SW, Gahring LC. 1998. Nicotine blocks TNF-α-mediated neuroprotection to NMDA by an α-bungarotoxin-sensitive pathway. J Neurobiol 35:29-36.
8. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. 1999. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163:3963-3968.
9. Cazevieille C, Muller A, Meynier F, Dutrait N, Bonne C. 1994. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int 24:395-398.
10. Chomczynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Choi DW. 1992. Excitotoxic cell death. J Neurobiol 23:1261-1276.
12. Coleman R-A, Smith WL, Narumiya S. 1994. International union of pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229.
13. 2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am J Physiol 275(Suppl):1812-1821.
14. Gahring LC, Carlson NG, Wieggel WA, Howard J, Rogers SW. 1999. Alcohol blocks TNF-alpha but not other cytokine-mediated neuroprotection to NMDA. Alcohol Clin Exp Res 23:1571-1579.
15. Gahring LC, White HS, Skradski SL, Carlson NG, Rogers SW. 1997. Interleukin-1α in the brain is induced by audiogenic seizure. Neurobiol Dis 3:263-269.
16. Grilli M, Pizzi M, Memo M, Spano P. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274:1383-1385.
17. Hampson A, Grimaldi J. 2002. 12-Hydroxyeicosatetrenocte (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: Evidence for a G-protein-coupled HGTE receptor. J Neurosci 22:257-264.
18. 2. FASEB J 5:2575-2581.
19. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. 2000. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293:417-425
20. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. 2001. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98:1294-1299.
21. Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ. 1998. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science 280:1268-1270.
22. Katoh H, Watabe A, Sugimoto Y, Ichikawa A, Negishi M. 1995. Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. Biochim Biophys Acta 1244:41-48.
23. Kaufmann WE, Andreasson LI, Isakson PC, Worley PF. 1997. Cyclooxygenases and the central nervous system. Prostaglandins 54:601-624.
24. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93:2317-2321.
25. Kelley KA, Ho L, Winger D, Freire-Moar J, Borelli CB, Aisen PS, Pasinetti GM. 1999. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol 155:995-1004.
26. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Naruyami S. 1997. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122:217-224.
27. Kunz T, Oliw E. 2001. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur J Neurosci 13:569-575.
28. Lawrence RA, Jones RL, Wilson NH. 1992. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br J Pharmacol 105:271-278.
29. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. 1997. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
30. Lee RK, Knapp S, Wurtman RJ. 1999. Prostaglandin E2 stimulates amyloid precursor protein gene expression: Inhibition by immunosuppressants. J Neurosci 19:940-947.
31. Lerea LS, Carlson NG, Simonato M, Morrow JD, Roberts JL, McNamara JO. 1997. Prostaglandin F2α is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons. J Neurosci 17:117-124.
32. Lipton SA. 1994. AIDS-related dementia and calcium homeostasis. Ann N Y Acad Sci 747:205-224.
33. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and non ulcerogenic. Proc Natl Acad Sci USA 91:3228-3232.
34. McGeer EG, McGeer PL. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 33:371-378.
35. Mirjany M, Ho L, Pasinetti GM. 2002. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J Pharmacol Exp Ther 301:494-500.
36. Nagayama M, Niwa K, Nagayama T, Ross ME, Iadecola C. 1999. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 19:1213-1219.
37. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. 1998. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95:10966-10971.
38. Nogawa S, Zhang F, Ross ME, Iadecola C. 1997. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746-2755.
39. Patel M, Day BJ, Crapo JD, Fridovich 1, McNamara JO. 1996. Requirement for superoxide in excitotoxic cell death. Neuron 16:345-355.
40. Prasad KN, Hovland AR, La Rosa FG, Hovland PG. 1998. Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc Soc Exp Biol Med 219:120-125.
41. Reitz DB, Li JJ, Norton MB, Reinhard EJ, Collins JT, Anderson GD, Gregory SA, Koboldt CM. Perkins WE, Seibert K, et al. 1994. Selective cyclooxygenase inhibitors: Novel 1,2-diarycyclopentenes are potent and orally active COX-2 inhibitors. J Med Chem 37:3878-3881.
42. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244.
43. Sanzgiri RP, Araque A, Haydon PG. 1999. Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells. J Neurobiol 41:221-229.
44. Sattler R, Tymianski M. 2000. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78:3-13.
45. Satoh K, Nagano Y, Shimomura C, Suzuki N, Saeki Y, Yokota H. 2000. Expression of prostaglandin E synthase mRNA is induced in beta-amyloid treated rat astrocytes. Neurosci Lett 283:221-223.
46. Smith WL, DeWitt DL. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Adv Immunol 62:167-215.
47. Stewart WF, Kawas C, Corrada M, Metter EJ. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
48. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T. 2002. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317:61-64
49. Watanabe Y, Matsumura K, Takechi H, Kato K, Morii H, Bjorkman M, Langstrom B, Noyori R, Suzuki M, Watanabe Y. 1999. A novel subtype of prostacyclin receptor in the central nervous system. J Neurochem 72:2583-2592.
50. Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L, Aisen P, Pasinetti S. 2002. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Neurobiol Aging 3:327-334.
51. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons by synaptic activity and glucocorticoids. Neuron 11:371-386.
52. Yamagata K, Matsumura K, Inoue W, Shiraki T, Suzuki K, Yasuda S, Sugiura H, Cao C, Watanabe Y, Kobayashi S. 2001. Coexpression of microsomal-type prostaglandin e synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21:2669-2677.